CN1084148C - 协同增效性除草混合物 - Google Patents

协同增效性除草混合物 Download PDF

Info

Publication number
CN1084148C
CN1084148C CN96198102A CN96198102A CN1084148C CN 1084148 C CN1084148 C CN 1084148C CN 96198102 A CN96198102 A CN 96198102A CN 96198102 A CN96198102 A CN 96198102A CN 1084148 C CN1084148 C CN 1084148C
Authority
CN
China
Prior art keywords
colby
dosage
usage amount
active
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN96198102A
Other languages
English (en)
Chinese (zh)
Other versions
CN1201370A (zh
Inventor
R·里斯
J·伯纳
E·日驰特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Yashima Chemical Industrial Co Ltd
Original Assignee
Hoechst Schering Agrevo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Schering Agrevo GmbH filed Critical Hoechst Schering Agrevo GmbH
Publication of CN1201370A publication Critical patent/CN1201370A/zh
Application granted granted Critical
Publication of CN1084148C publication Critical patent/CN1084148C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN96198102A 1995-11-15 1996-11-12 协同增效性除草混合物 Expired - Lifetime CN1084148C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19544393.4 1995-11-15
DE19544393A DE19544393A1 (de) 1995-11-15 1995-11-15 Synergistische herbizide Mischungen

Publications (2)

Publication Number Publication Date
CN1201370A CN1201370A (zh) 1998-12-09
CN1084148C true CN1084148C (zh) 2002-05-08

Family

ID=7778639

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96198102A Expired - Lifetime CN1084148C (zh) 1995-11-15 1996-11-12 协同增效性除草混合物

Country Status (18)

Country Link
US (1) US6013605A (OSRAM)
EP (1) EP0863705B1 (OSRAM)
JP (1) JP3920341B2 (OSRAM)
KR (1) KR100427960B1 (OSRAM)
CN (1) CN1084148C (OSRAM)
AU (1) AU711841B2 (OSRAM)
BR (1) BR9611478A (OSRAM)
CA (1) CA2236592C (OSRAM)
DE (2) DE19544393A1 (OSRAM)
ES (1) ES2178720T3 (OSRAM)
MX (1) MX9803824A (OSRAM)
MY (1) MY114731A (OSRAM)
RU (1) RU2170017C2 (OSRAM)
TR (1) TR199800794T2 (OSRAM)
TW (1) TW355125B (OSRAM)
UA (1) UA48203C2 (OSRAM)
WO (1) WO1997017852A1 (OSRAM)
ZA (1) ZA969564B (OSRAM)

Families Citing this family (255)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836684A1 (de) * 1998-08-13 2000-02-17 Hoechst Schering Agrevo Gmbh Herbizide Mittel für tolerante oder resistente Reiskulturen
KR100338621B1 (ko) * 2000-01-24 2002-05-30 전광술 제초제 및 그 제조방법
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
CA2633595A1 (en) 2001-06-20 2003-01-03 Genentech, Inc. Antibodies against tumor-associated antigenic target (tat) polypeptides
EP1420644B1 (de) 2001-08-23 2006-05-31 Bayer CropScience S.A. Substituierte propargylamine
KR101008758B1 (ko) 2001-09-18 2011-01-14 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
KR100801388B1 (ko) 2002-01-02 2008-02-05 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
KR100429139B1 (ko) * 2002-02-28 2004-04-29 한국화학연구원 싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법
NZ535925A (en) 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
EP2305710A3 (en) 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
DK1610820T4 (da) 2003-04-04 2013-11-04 Genentech Inc Høj-koncentration antistof- og proteinformuleringer
US6849579B2 (en) * 2003-06-25 2005-02-01 Pbi Gordon Corporation Synergistic quinclorac herbicidal compositions
EP1641822B1 (en) 2003-07-08 2013-05-15 Genentech, Inc. Il-17 a/f heterologous polypeptides and therapeutic uses thereof
NZ596984A (en) 2003-11-17 2013-10-25 Genentech Inc Compositions and methods for the treatment of tumor of hematopoietic origin
JP4570890B2 (ja) * 2004-03-26 2010-10-27 協友アグリ株式会社 除草剤組成物
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
MX2007008768A (es) 2005-01-21 2007-10-19 Genentech Inc Dosificacion fija de anticuerpos her.
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
CN103251946A (zh) 2005-02-23 2013-08-21 健泰科生物技术公司 使用her二聚化抑制剂在癌症患者中延长病情进展前时间或存活
WO2006091332A2 (en) 2005-02-23 2006-08-31 Alza Corporation Intranasal administration of active agents to the central nervous system
JP5167473B2 (ja) 2005-03-03 2013-03-21 コヴェックス・テクノロジーズ・アイルランド・リミテッド 抗血管新生化合物
CA2610709A1 (en) 2005-06-06 2006-12-14 Genentech, Inc. Transgenic models for different genes and their use for gene characterization
ZA200800970B (en) 2005-08-15 2009-10-28 Genentech Inc Gene disruptions, compositions and methods relating thereto
EP1962584A2 (en) 2005-11-21 2008-09-03 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
US20080311107A1 (en) 2006-02-17 2008-12-18 Genetech, Inc. Novel Gene Disruptions, Compositions and Methods Relating Thereto
MY159375A (en) 2006-03-21 2016-12-30 Genentech Inc Combinatorial therapy
EP2614839A3 (en) 2006-04-05 2015-01-28 Genentech, Inc. Method for using BOC/CDO to modulate hedgehog signaling
CA2649387A1 (en) 2006-04-19 2008-03-27 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
CA2654000A1 (en) 2006-06-06 2008-05-22 Genentech, Inc. Anti-dll4 antibodies and methods using same
US8874380B2 (en) 2010-12-09 2014-10-28 Rutgers, The State University Of New Jersey Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
JP5244103B2 (ja) 2006-08-09 2013-07-24 ホームステッド クリニカル コーポレイション 器官特異的蛋白質およびその使用方法
ES2399075T3 (es) 2006-08-30 2013-03-25 Genentech, Inc. Anticuerpos multiespecíficos
KR20120043028A (ko) 2006-11-10 2012-05-03 씨오브이엑스 테크놀로지스 아일랜드 리미티드 혈관 신생 억제 화합물
NZ578980A (en) 2007-02-22 2012-03-30 Genentech Inc Methods for detecting inflammatory bowel disease
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
ES2417148T3 (es) 2007-06-08 2013-08-06 Genentech, Inc. Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2
MY150531A (en) 2007-07-16 2014-01-30 Genentech Inc Anti-cd79b antibodies and immunoconjugates and methods of use
RU2557319C2 (ru) 2007-07-16 2015-07-20 Дженентек, Инк. ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ CD79b И ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ПРИМЕНЕНИЯ
BRPI0820707A2 (pt) 2007-11-07 2015-06-16 Genentech Inc Métodos e composição para avaliar a responsividade do linfoma de células b para o tratamento com anticorpos anti-cd40
CN102089324B (zh) 2007-11-12 2014-04-16 特罗科隆科学有限公司 用于对流行性感冒进行治疗以及诊断的组合物以及方法
DK2657253T3 (en) 2008-01-31 2017-10-09 Genentech Inc Anti-CD79b antibodies and immune conjugates and methods of use
ES2542308T3 (es) 2008-03-10 2015-08-04 Theraclone Sciences, Inc. Composiciones y métodos para la terapia y diagnóstico de infecciones por citomegalovirus
RU2607569C2 (ru) 2008-03-31 2017-01-10 Дженентек, Инк. Композиции и способы для лечения и диагностики астмы
US20100255508A1 (en) 2008-05-16 2010-10-07 Thomas Richard Gelzleichter Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
CN102316897B (zh) 2008-07-08 2014-11-05 昂考梅德药品有限公司 Notch结合剂和拮抗剂及其应用方法
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
CN101352171B (zh) * 2008-09-19 2012-07-04 北京燕化永乐农药有限公司 吡嘧磺隆与甲羧除草醚农药的除草剂组合物
EP2349332B1 (en) 2008-11-13 2019-10-23 The General Hospital Corporation Methods and compositions for regulating iron homeostasis by modulation bmp-6
US8211434B2 (en) 2008-11-26 2012-07-03 Allergan, Inc. KLK-13 antibody inhibitor for treating dry eye
WO2010077634A1 (en) 2008-12-09 2010-07-08 Genentech, Inc. Anti-pd-l1 antibodies and their use to enhance t-cell function
SI3260136T1 (sl) 2009-03-17 2021-05-31 Theraclone Sciences, Inc. Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
CN102356092B (zh) 2009-03-20 2014-11-05 霍夫曼-拉罗奇有限公司 双特异性抗-her抗体
AR075998A1 (es) 2009-04-01 2011-05-11 Genentech Inc Tratamiento de trastornos resistentes a insulina.composicion farmaceutica. uso. kit
SG174992A1 (en) 2009-04-01 2011-11-28 Genentech Inc Anti-fcrh5 antibodies and immunoconjugates and methods of use
WO2010118243A2 (en) 2009-04-08 2010-10-14 Genentech, Inc. Use of il-27 antagonists to treat lupus
US9617600B2 (en) 2009-04-18 2017-04-11 Genentech, Inc. Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
US8609101B2 (en) 2009-04-23 2013-12-17 Theraclone Sciences, Inc. Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies
EP2432803A2 (en) 2009-05-20 2012-03-28 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
WO2011019679A1 (en) 2009-08-11 2011-02-17 Allergan, Inc. Ccr2 inhibitors for treating conditions of the eye
CA2778442A1 (en) 2009-10-22 2011-04-28 Genentech, Inc. Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
WO2011056497A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Activin receptor type iib compositions and methods of use
WO2011056502A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Bone morphogenetic protein receptor type ii compositions and methods of use
WO2011056494A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
NZ599600A (en) 2009-10-26 2015-04-24 Genentech Inc Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
AU2010324686B2 (en) 2009-11-30 2016-05-19 Genentech, Inc. Antibodies for treating and diagnosing tumors expressing SLC34A2 (TAT211 = SEQID2 )
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011082187A1 (en) 2009-12-30 2011-07-07 Genentech, Inc. Methods for modulating a pdgf-aa mediated biological response
MX2012009215A (es) 2010-02-23 2012-11-23 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2011133931A1 (en) 2010-04-22 2011-10-27 Genentech, Inc. Use of il-27 antagonists for treating inflammatory bowel disease
JP2013525484A (ja) 2010-05-03 2013-06-20 ジェネンテック， インコーポレイテッド タンパク質含有製剤の粘度を低減させるために有用な組成物及び方法
AU2011250970B2 (en) 2010-05-10 2016-12-15 Sinica, Academia Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CN102265853A (zh) * 2010-06-04 2011-12-07 南京华洲药业有限公司 一种含灭草松和二氯喹啉酸的除草组合物及其应用
US20110311527A1 (en) 2010-06-16 2011-12-22 Allergan, Inc. IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
AU2011289275A1 (en) 2010-08-12 2013-02-21 Theraclone Sciences, Inc. Anti-hemagglutinin antibody compositions and methods of use thereof
EP2420250A1 (en) 2010-08-13 2012-02-22 Universitätsklinikum Münster Anti-Syndecan-4 antibodies
US20130177555A1 (en) 2010-08-13 2013-07-11 Medimmune Limited Monomeric Polypeptides Comprising Variant FC Regions And Methods Of Use
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
EP2611465A4 (en) 2010-08-31 2014-06-04 Theraclone Sciences Inc ANTIBODIES FOR NEUTRALIZING THE HUMAN IMMUNODICITY VIRUS (HIV)
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
CA2827301A1 (en) 2011-02-14 2012-08-23 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
AU2012229188A1 (en) 2011-03-15 2013-09-26 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
CN109734807A (zh) 2011-03-31 2019-05-10 豪夫迈·罗氏有限公司 施用β7整联蛋白拮抗剂的方法
BR122020001787A8 (pt) 2011-05-08 2023-04-25 Legochem Biosciences Inc Conjugado de anticorpo-agente ativo, seus métodos de preparação, sua composição e seu uso
EP3865507A1 (en) 2011-05-17 2021-08-18 The Rockefeller University Human immunodeficiency virus neutralizing antibodies and methods of use thereof
EP2718327A1 (en) 2011-06-06 2014-04-16 Neotope Biosciences Limited Mcam antagonists and methods of treatment
JP2013040160A (ja) 2011-07-01 2013-02-28 Genentech Inc 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用
WO2013015821A1 (en) 2011-07-22 2013-01-31 The Research Foundation Of State University Of New York Antibodies to the b12-transcobalamin receptor
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
US9493549B2 (en) 2011-07-25 2016-11-15 The Rockefeller University Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
WO2013016468A2 (en) 2011-07-25 2013-01-31 California Institute Of Technology Compositions and methods for improving potency and breadth or hiv antibodies
WO2013033069A1 (en) 2011-08-30 2013-03-07 Theraclone Sciences, Inc. Human rhinovirus (hrv) antibodies
CA2863224A1 (en) 2012-01-09 2013-07-18 The Scripps Research Institute Ultralong complementarity determining regions and uses thereof
JP2015509091A (ja) 2012-01-09 2015-03-26 ザ スクリプス リサーチ インスティテュート ヒト化抗体
JP2015506950A (ja) 2012-01-31 2015-03-05 ジェネンテック， インコーポレイテッド 抗ｉｇ−ｅｍ１’抗体およびそれを用いる方法
JP2015514710A (ja) 2012-03-27 2015-05-21 ジェネンテック， インコーポレイテッド Ｈｅｒ３阻害剤に関する診断及び治療
MX370486B (es) 2012-03-27 2019-12-16 Genentech Inc Composiciones, métodos y usos para asistir en el diagnóstico, pronóstico y tratamiento de la fibrosis pulmonar idiopática.
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013192589A1 (en) 2012-06-21 2013-12-27 California Institute Of Technology Antibodies targeting hiv escape mutants
WO2014018375A1 (en) 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 and uses thereof in therapeutic and diagnostic methods
EP2885311B1 (en) 2012-08-18 2020-01-01 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
CA2883168A1 (en) 2012-08-21 2014-02-27 Academia Sinica Benzocyclooctyne compounds and uses thereof
TWI660972B (zh) 2012-09-10 2019-06-01 愛爾蘭商尼歐托普生物科學公司 抗ｍｃａｍ抗體及相關使用方法
AU2013326921C1 (en) 2012-10-05 2018-01-18 Genentech, Inc. Methods for diagnosing and treating inflammatory bowel disease
IL285049B (en) 2012-10-18 2022-07-01 California Inst Of Techn Broad-spectrum neutralizing antibodies against the AIDS virus
WO2014063205A1 (en) 2012-10-26 2014-05-01 The University Of Queensland Use of endocytosis inhibitors and antibodies for cancer therapy
EP3495814A3 (en) 2013-03-27 2019-07-17 F. Hoffmann-La Roche AG Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
US20160053023A1 (en) 2013-04-09 2016-02-25 Annexon, Inc. Methods of treatment for neuromyelitis optica
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
KR102321320B1 (ko) 2013-07-09 2021-11-03 애넥슨, 인코포레이티드 항-보체 인자 ｃ１ｑ 항체 및 이의 용도
US20160168231A1 (en) 2013-07-18 2016-06-16 Fabrus, Inc. Antibodies with ultralong complementarity determining regions
CN105814074B (zh) 2013-07-18 2020-04-21 图鲁斯生物科学有限责任公司 具有超长互补决定区的人源化抗体
KR102298172B1 (ko) 2013-09-06 2021-09-06 아카데미아 시니카 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
WO2015050959A1 (en) 2013-10-01 2015-04-09 Yale University Anti-kit antibodies and methods of use thereof
BR112016011027A2 (pt) 2013-12-20 2017-12-05 Genentech Inc método de produção de um anticorpo, anticorpos, composição farmacêutica, polinucleotídeo, vetor, célula hospedeira, método de tratamento de asma e método de tratamento de um distúrbio
CA2936488C (en) 2014-01-14 2022-05-03 The Medical College Of Wisconsin, Inc. Targeting clptm1l for treatment and prevention of cancer
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
KR20160104727A (ko) 2014-01-16 2016-09-05 아카데미아 시니카 암의 치료 및 검출을 위한 조성물 및 방법
WO2015116902A1 (en) 2014-01-31 2015-08-06 Genentech, Inc. G-protein coupled receptors in hedgehog signaling
MA39804A (fr) 2014-03-27 2017-02-01 Hoffmann La Roche Méthodes permettant le diagnostic et le traitement d'une maladie inflammatoire de l'intestin
TWI797430B (zh) 2014-03-27 2023-04-01 中央研究院 反應性標記化合物及其用途
CN104012549B (zh) * 2014-05-07 2016-08-17 广东中迅农科股份有限公司 一种含有双唑草腈和双草醚的除草组合物
CN104012547A (zh) * 2014-05-07 2014-09-03 广东中迅农科股份有限公司 一种含有双唑草腈和氰氟草酯的除草组合物
WO2015175874A2 (en) 2014-05-16 2015-11-19 Medimmune, Llc Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
KR20240096599A (ko) 2014-05-27 2024-06-26 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
AU2015267052A1 (en) 2014-05-27 2016-12-15 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
US10005847B2 (en) 2014-05-27 2018-06-26 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗ＴＮＦα糖操作抗体群およびその使用
TWI689520B (zh) 2014-05-30 2020-04-01 漢霖生技股份有限公司 抗表皮生長因子受體（ｅｇｆｒ）抗體
SG11201700901SA (en) 2014-08-08 2017-03-30 Alector Llc Anti-trem2 antibodies and methods of use thereof
CN107001404B (zh) 2014-09-08 2021-06-29 中央研究院 使用醣脂激活人类iNKT细胞
CN104255750A (zh) * 2014-09-10 2015-01-07 广东中迅农科股份有限公司 含有双唑草腈和丙草胺的除草组合物
WO2016073157A1 (en) 2014-11-06 2016-05-12 Genentech, Inc. Anti-ang2 antibodies and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
JP6789954B2 (ja) 2015-01-22 2020-11-25 ビーエーエスエフ アグロ ベー．ブイ． サフルフェナシルを含む３成分除草剤の組合せ
TWI736523B (zh) 2015-01-24 2021-08-21 中央研究院 新穎聚醣結合物及其使用方法
EP3250927B1 (en) 2015-01-28 2020-02-19 H. Hoffnabb-La Roche Ag Gene expression markers and treatment of multiple sclerosis
JP2018507868A (ja) 2015-02-26 2018-03-22 ジェネンテック， インコーポレイテッド インテグリンベータ７アンタゴニスト及びクローン病の治療方法
KR102721595B1 (ko) 2015-04-03 2024-10-23 유레카 쎄라퓨틱스, 인코포레이티드 Afp 펩티드/mhc 복합체를 표적화하는 구축물 및 그의 용도
LT3280441T (lt) 2015-04-07 2021-11-25 Alector Llc Anti-sortilino antikūnai ir jų naudojimo būdai
CN104757013A (zh) * 2015-04-18 2015-07-08 广东中迅农科股份有限公司 含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物
EP3302710A4 (en) 2015-06-03 2019-02-20 The University of Queensland MOBILIZERS AND USE THEREOF
CN107922480B (zh) 2015-06-12 2022-09-23 艾利妥 抗cd33抗体及其使用方法
HK1252675A1 (zh) 2015-06-12 2019-05-31 Alector Llc 抗cd33抗体及其使用方法
US11219212B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and imazamox
PL3319435T3 (pl) 2015-07-10 2020-07-27 BASF Agro B.V. Kompozycja chwastobójcza zawierająca cynmetalinę i chlomazon
US10980232B2 (en) 2015-07-10 2021-04-20 BASF Agro B.V. Herbicidal composition comprising cinmethylin and pyroxasulfone
WO2017009061A1 (en) 2015-07-10 2017-01-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and saflufenacil
AU2016292678B2 (en) 2015-07-10 2020-12-24 BASF Agro B.V. Method for controlling herbicide resistant or tolerant weeds
KR102549057B1 (ko) 2015-07-10 2023-06-29 바스프 아그로 비.브이. 신메틸린 및 아세토클로르 또는 프레틸라클로르를 포함하는 제초제 조성물
US20180199568A1 (en) 2015-07-10 2018-07-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and pethoxamid
PL3319427T3 (pl) 2015-07-10 2020-05-18 BASF Agro B.V. Kompozycja chwastobójcza zawierająca cynmetalinę i dimetenamid
MY189172A (en) 2015-07-10 2022-01-31 Basf Agro Bv Herbicidal composition comprising cinmethylin and specific quinolinecarboxylic acids
US11219215B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase
CN105076162B (zh) * 2015-08-05 2018-03-09 安徽华星化工有限公司 一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物
JP7525980B2 (ja) 2015-08-28 2024-07-31 アレクトル エルエルシー 抗Ｓｉｇｌｅｃ－７抗体及びその使用方法
JP7725185B2 (ja) 2015-10-06 2025-08-19 アレクトル エルエルシー 抗ｔｒｅｍ２抗体及びその使用方法
AU2016342041B2 (en) 2015-10-23 2021-12-02 Eureka Therapeutics, Inc. Antibody/T-cell receptor chimeric constructs and uses thereof
JP7060502B2 (ja) 2015-10-29 2022-04-26 アレクトル エルエルシー 抗Ｓｉｇｌｅｃ－９抗体及びその使用方法
RS65660B1 (sr) 2015-11-25 2024-07-31 Ligachem Biosciences Inc Konјugati koji sadrže samozapaljive grupe i postupci povezani sa njima
US10525137B2 (en) 2015-12-30 2020-01-07 Genentech, Inc. Formulations with reduced degradation of polysorbate
US11472877B2 (en) 2016-03-04 2022-10-18 Alector Llc Anti-TREM1 antibodies and methods of use thereof
CA3016170A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
CN105901005A (zh) * 2016-05-16 2016-08-31 河北博嘉农业有限公司 一种含有双唑草腈的除草组合物
CN105918339A (zh) * 2016-05-19 2016-09-07 河北博嘉农业有限公司 一种含有双唑草腈和磺酰脲类除草剂的除草组合物
WO2018014260A1 (en) 2016-07-20 2018-01-25 Nanjing Legend Biotech Co., Ltd. Multispecific antigen binding proteins and methods of use thereof
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
CN109923126B (zh) 2016-09-16 2022-06-03 上海复宏汉霖生物技术股份有限公司 抗-pd-1抗体
WO2018068201A1 (en) 2016-10-11 2018-04-19 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies and variants thereof against ctla-4
CN108064866A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064871A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064868A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064865A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064860A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN106561695A (zh) * 2016-11-15 2017-04-19 江苏龙灯化学有限公司 一种除草组合物
KR102085798B1 (ko) 2016-12-28 2020-03-06 주식회사 인투셀 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
WO2018132597A1 (en) 2017-01-12 2018-07-19 Eureka Therapeutics, Inc. Constructs targeting histone h3 peptide/mhc complexes and uses thereof
WO2018152496A1 (en) 2017-02-17 2018-08-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Compositions and methods for the diagnosis and treatment of zika virus infection
CN107047593A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与乙氧磺隆的除草组合物及其应用
CN106857600A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与异丙隆的除草组合物及其应用
CN106857621A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与禾草敌的除草组合物及其应用
CN106889082A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与噁草酮的除草组合物及其应用
CN106857576A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与苯噻酰草胺的除草组合物及其应用
CN106889084A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与灭草松的除草组合物及其应用
CN106857577A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与氟硫草定的除草组合物及其应用
CN106857579A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与三嗪氟草胺的除草组合物及其应用
CN107047594A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用
CN106889094A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与吡嘧磺隆的除草组合物及其应用
CN106857580A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与吡氟酰草胺的除草组合物及其应用
CN106857578A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙草胺的除草组合物及其应用
CN106889083B (zh) * 2017-02-27 2019-02-12 南京华洲药业有限公司 一种含双唑草腈与异恶草酮的除草组合物及其应用
CN106857609A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用
CN106857575A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与丁草胺的除草组合物及其应用
CN107047582A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与禾草畏的除草组合物及其应用
CN107047578A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与丙炔噁草酮的除草组合物及其应用
CN107047592A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与苄嘧磺隆的除草组合物及其应用
RU2665790C1 (ru) 2017-04-17 2018-09-04 Закрытое Акционерное Общество "Биокад" Моноклональное антитело к pd-l1
WO2018200742A1 (en) 2017-04-25 2018-11-01 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
WO2018200585A1 (en) 2017-04-26 2018-11-01 Eureka Therapeutics, Inc. Cells expressing chimeric antigen receptors and secondary effectors and uses thereof
EP3615574A4 (en) 2017-04-26 2021-02-24 Eureka Therapeutics, Inc. SPECIFIC GLYPICAN 3 RECOGNIZING CONSTRUCTS AND THEIR USE
US11359014B2 (en) 2017-05-16 2022-06-14 Alector Llc Anti-siglec-5 antibodies and methods of use thereof
CN107114382A (zh) * 2017-05-22 2017-09-01 娄天成 一种含双唑草腈和敌稗的农药组合物及其应用
CN107094781A (zh) * 2017-05-22 2017-08-29 孙金金 一种含双唑草腈和二氯喹啉酸的农药组合物及其应用
CN106954634A (zh) * 2017-05-22 2017-07-18 娄天成 一种含双唑草腈和莎稗磷的农药组合物及其应用
US11530273B2 (en) 2017-05-23 2022-12-20 Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Anti-CD73 monoclonal antibody, encoding nucleic acids and method for producing
CN107006498A (zh) * 2017-05-24 2017-08-04 江苏省农用激素工程技术研究中心有限公司 用于防除稻田杂草的除草组合物
RU2653545C1 (ru) * 2017-07-17 2018-05-11 АО "Щелково Агрохим" Гербицидная композиция на основе бентазона для защиты зернобобовых культур
EP3655430A1 (en) 2017-07-19 2020-05-27 The U.S.A. as represented by the Secretary, Department of Health and Human Services Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
PE20200486A1 (es) 2017-08-03 2020-03-03 Alector Llc Anticuerpos anti-cd33 y metodos para utilizarlos
HRP20230675T1 (hr) 2017-08-03 2023-09-29 Alector Llc Anti-trem2 protutijela i postupci njihove uporabe
RU2698048C2 (ru) 2017-10-03 2019-08-21 Закрытое Акционерное Общество "Биокад" МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
EA039662B1 (ru) 2017-10-03 2022-02-24 Закрытое Акционерное Общество "Биокад" Антитела, специфичные к cd47 и pd-l1
CA3085472A1 (en) 2017-12-19 2019-06-27 The Rockefeller University Human igg fc domain variants with improved effector function
CN117050184A (zh) 2017-12-28 2023-11-14 南京传奇生物科技有限公司 针对tigit的单域抗体和其变体
JP7366908B2 (ja) 2018-01-15 2023-10-23 ナンジン レジェンド バイオテック カンパニー，リミテッド Ｐｄ－１に対する単一ドメイン抗体及びその変異体
JP7542257B2 (ja) 2018-01-25 2024-08-30 エイシーエム バイオラブズ プライベート リミテッド 可溶化された封入抗原を含むポリマーソーム、ならびにその作製および使用方法
CN108371183A (zh) * 2018-02-02 2018-08-07 河北中天邦正生物科技股份公司 一种农药组合物及其应用
CN108308187A (zh) * 2018-02-11 2018-07-24 河北中天邦正生物科技股份公司 一种农药组合物及其应用
AU2019241350B2 (en) 2018-03-30 2025-10-02 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies against LAG-3 and uses thereof
US12084489B2 (en) 2018-05-02 2024-09-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
CN119841953A (zh) 2018-06-08 2025-04-18 艾利妥 抗siglec-7抗体及其使用方法
CA3103936A1 (en) 2018-06-18 2019-12-26 Eureka Therapeutics, Inc. Constructs targeting prostate-specific membrane antigen (psma) and uses thereof
PE20210186A1 (es) 2018-07-13 2021-02-02 Alector Llc Anticuerpos anti-sortilina y metodos para su uso
JP7447388B2 (ja) 2018-07-13 2024-03-12 ナンジン レジェンド バイオテック カンパニー，リミテッド 感染性疾患の治療のための共受容体システム
SG11202100555PA (en) 2018-07-27 2021-02-25 Alector Llc Anti-siglec-5 antibodies and methods of use thereof
BR112021003016A2 (pt) 2018-08-31 2021-05-18 Alector Llc anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, métodos para produzir um anticorpo e para prevenir, reduzir o risco ou tratar uma doença e composição farmacêutica
EP3849600A1 (en) 2018-09-12 2021-07-21 ACM Biolabs Pte Ltd Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof
EP3849612A4 (en) 2018-09-14 2022-07-06 The Rockefeller University ANTI-HIV ANTIBODIES 10-1074 VARIANTS
WO2020086328A1 (en) 2018-10-25 2020-04-30 The Medical College Of Wisconsin, Inc. Targeting clptm1l for treatment and prevention of cancer
RU2724469C2 (ru) 2018-10-31 2020-06-23 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с cd20
EA202191058A1 (ru) 2018-11-16 2021-10-07 Мемориал Слоун Кеттеринг Кэнсер Сентр Антитела против муцина-16 и способы их применения
WO2020108423A1 (en) 2018-11-27 2020-06-04 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereof
RU2734432C1 (ru) 2019-04-23 2020-10-16 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с GITR
WO2020222573A1 (ko) 2019-05-02 2020-11-05 주식회사 레고켐 바이오사이언스 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체
CN114040754A (zh) 2019-06-28 2022-02-11 基因泰克公司 用于稳定液体蛋白质制剂的组合物及方法
CN110178842A (zh) * 2019-07-05 2019-08-30 南京农业大学 一种丙草胺与双唑草腈治理抗性稗组合物及其应用
PH12022550030A1 (en) 2019-07-09 2022-11-21 Beijing Solobio Genetechnology Co Ltd Antibodies specifically recognizing pseudomonas pcrv and uses thereof
BR112022000876A2 (pt) 2019-07-19 2022-04-26 Oncoresponse Inc Anticorpos imunomoduladores e métodos de uso destes
CN112300279A (zh) 2019-07-26 2021-02-02 上海复宏汉霖生物技术股份有限公司 针对抗cd73抗体和变体的方法和组合物
WO2021238886A1 (en) 2020-05-27 2021-12-02 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibodies specifically recognizing nerve growth factor and uses thereof
US20240092926A1 (en) 2021-01-20 2024-03-21 Oncoresponse, Inc. Immunomodulatory antibodies and uses thereof
EP4322922A1 (en) 2021-04-12 2024-02-21 ACM Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
US20250011448A1 (en) 2021-07-08 2025-01-09 Staidson Biopharma Inc. Antibodies specifically recognizing tnfr2 and uses thereof
US20240343817A1 (en) 2021-07-14 2024-10-17 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibody that specifically recognizes cd40 and application thereof
US20250066458A1 (en) 2021-12-06 2025-02-27 Beijing Solobio Genetechnology Co., Ltd. Bispecific Antibodies Specifically Binding to Klebsiella Pneumoniae O2 Antigen and O1 Antigen and Compositions Thereof
WO2023217068A1 (zh) 2022-05-09 2023-11-16 舒泰神（北京）生物制药股份有限公司 特异性识别gdf15的抗体及其应用
TW202417503A (zh) 2022-07-19 2024-05-01 美商舒泰神（加州）生物科技有限公司 特異性識別ｂ和ｔ淋巴細胞衰減器（ｂｔｌａ）的抗體及其應用
CN119998321A (zh) 2022-09-27 2025-05-13 舒泰神（北京）生物制药股份有限公司 特异性识别light的抗体及其应用
AU2023365967A1 (en) 2022-10-20 2025-06-05 Beijing Solobio Genetechnology Co., Ltd. Antibody combination specifically binding to trail or fasl, and bispecific antibody
WO2025224166A1 (en) 2024-04-23 2025-10-30 F. Hoffmann-La Roche Ag Anti-drug antibody assays
WO2025233867A1 (en) 2024-05-10 2025-11-13 Adaptam Therapeutics, S.L. Anti-siglec-9 antibodies and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542388A1 (en) * 1991-11-13 1993-05-19 Schering Aktiengesellschaft New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
WO1994008999A1 (en) * 1992-10-12 1994-04-28 Schering Aktiengesellschaft New substituted pyrazole derivatives, processes for their preparation and their use as herbicides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY136106A (en) * 1990-09-06 2008-08-29 Novartis Ag Synergistic composition comprising a sulfonylurea anda thiadiazolo (3,4-a)pyridazine and method of selective weed control.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542388A1 (en) * 1991-11-13 1993-05-19 Schering Aktiengesellschaft New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
WO1994008999A1 (en) * 1992-10-12 1994-04-28 Schering Aktiengesellschaft New substituted pyrazole derivatives, processes for their preparation and their use as herbicides

Also Published As

Publication number Publication date
BR9611478A (pt) 1999-07-13
ZA969564B (en) 1997-05-15
DE19544393A1 (de) 1997-05-22
TR199800794T2 (xx) 1998-08-21
UA48203C2 (uk) 2002-08-15
KR19990067314A (ko) 1999-08-16
CN1201370A (zh) 1998-12-09
JP3920341B2 (ja) 2007-05-30
DE59609348D1 (de) 2002-07-18
KR100427960B1 (ko) 2005-01-15
AU711841B2 (en) 1999-10-21
JP2000500445A (ja) 2000-01-18
WO1997017852A1 (de) 1997-05-22
MY114731A (en) 2002-12-31
CA2236592C (en) 2005-01-04
EP0863705B1 (de) 2002-06-12
TW355125B (en) 1999-04-01
EP0863705A1 (de) 1998-09-16
US6013605A (en) 2000-01-11
CA2236592A1 (en) 1997-05-22
RU2170017C2 (ru) 2001-07-10
AU7569696A (en) 1997-06-05
ES2178720T3 (es) 2003-01-01
MX9803824A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
CN1084148C (zh) 协同增效性除草混合物
CN1041592C (zh) 除草组合物及其选择性防除杂草的用途
CN1214725C (zh) 含有羟苯基丙酮酸盐双加氧酶抑制剂类的除草剂的增效除草组合物
CN1130122C (zh) 除草混合物
CN1022284C (zh) 除草组合物
CN1303880C (zh) 包含环己烯酮肟醚的增效除草混合物
CN1068472A (zh) 增效除草剂
CN1129517A (zh) 基于芳基尿嘧啶类的用于水稻栽培中的除莠剂
CN1201658C (zh) 除草制剂
CN1078852A (zh) 防治稻田杂草的除草剂
CN1310583A (zh) 除草组合物
CN1794911A (zh) 新安全剂及其应用
CN1436044A (zh) 杀菌剂活性化合物组合物
CN1589099A (zh) 含有选自苯甲酰基吡唑类除草剂的增效除草组合物
CN101080172A (zh) 除草组合物
CN1679396A (zh) 增效除草混合物
CN1039417A (zh) 取代磺酰二胺类，它们的制备方法及作为除草剂和植物生长调节剂的应用
CN1968604A (zh) 除草组合物
CN1252692A (zh) 杀菌活性化合物的组合物
CN1528764A (zh) 除草剂o，o-二甲基-1-（2，4-二氯苯氧乙酰氧基）乙基膦酸酯及其除草组合物
CN1046183C (zh) 增效除草剂
CN1056395A (zh) 包括2-氯-6-硝基-3-苯氧基苯胺和选自溴苯腈或碘苯腈或一种它们的衍生物的至少一种除草剂的除草组合物
CN1189763A (zh) 包含4－碘－2－[3－(4－甲氧基－6－甲基－1,3,5－三嗪－2－基)脲基磺酰基]苯甲酸酯的除草组合物
CN1313035A (zh) 除草剂组合物及其应用
CN1698435A (zh) 含除草剂o，o－二甲基－1－（2，4－二氯苯氧乙酰氧基）乙基膦酸酯的除草组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: YASHIMA CHEMICAL INDUSTRY CO., LTD.

Free format text: FORMER OWNER: BAYER CROP SCIENCE GMBH

Effective date: 20050325

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: AVENTIS CROPSCIENCE GMBH

Free format text: FORMER NAME OR ADDRESS: HOECHST SCHERING CO. LTD,.

Owner name: BAYER CROP SCIENCE GMBH

Free format text: FORMER NAME OR ADDRESS: AVENTIS CROPSCIENCE GMBH

CP01 Change in the name or title of a patent holder

Address after: Berlin, Federal Republic of Germany

Patentee after: AVENTIS CROPSCIENCE GmbH

Address before: Berlin, Federal Republic of Germany

Patentee before: Hechester-Sherin Agricultural Development Co.,Ltd.

Address after: Berlin, Federal Republic of Germany

Patentee after: BAYER CROPSCIENCE GmbH

Address before: Berlin, Federal Republic of Germany

Patentee before: AVENTIS CROPSCIENCE GmbH

TR01 Transfer of patent right

Effective date of registration: 20050325

Address after: Kanagawa, Japan

Patentee after: Yashima Chemical Industrial Co.,Ltd.

Address before: Berlin, Federal Republic of Germany

Patentee before: BAYER CROPSCIENCE GmbH

CX01 Expiry of patent term

Granted publication date: 20020508

EXPY Termination of patent right or utility model